Aurobindo Pharma CEO Arvind Vasudeva resigns
Recently, the drug firm had said that it intends to invest up to Rs 900 crore this fiscal on various activities including capacity expansion, clinical trials and product filings.
Jul 01, 2015, 17:09 PM IST